[
  {
    "Status": "Dormant",
    "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18029",
    "DIN": "02023709",
    "Company": "PHARMA STULLN INC. \n \n 6500 Trans Canada Highway, Suite 400 \n \n Pointe-Claire \n \n Quebec \n \n Canada \n H9R 0A5",
    "Product": "BALANCED SALT SOLUTION",
    "Class": "Human",
    "PM See footnote1": "No",
    "Schedule": "Ethical",
    "# See footnote2": "6",
    "A.I. name See footnote3": "Active ingredient(s) \n See footnote 8",
    "Strength": "Strength",
    "Current status date": "2019-09-30",
    "Original market date": "1994-12-31",
    "Address": "6500 Trans Canada Highway, Suite 400",
    "City": "Pointe-Claire",
    "state": "Quebec",
    "Country": "Canada",
    "Zipcode": "H9R 0A5",
    "Number of active ingredient(s)": "6",
    "Biosimilar Biologic Drug": "No",
    "American Hospital Formulary Service (AHFS)": "40:36.00",
    "Anatomical Therapeutic Chemical (ATC)": "B05CB10 COMBINATIONS",
    "Active ingredient group (AIG) number": "0600055001",
    "Labelling": "",
    "Product Monograph/Veterinary Date": "",
    "List of active ingredient": "Active ingredient(s) \n See footnote 8 : Strength\nCALCIUM CHLORIDE : 0.48 MG / ML\nMAGNESIUM CHLORIDE : 0.3 MG / ML\nPOTASSIUM CHLORIDE : 0.75 MG / ML\nSODIUM ACETATE : 3.9 MG / ML\nSODIUM CHLORIDE : 6.4 MG / ML\nSODIUM CITRATE : 1.7 MG / ML",
    "Dosage form": "Solution",
    "Route(s) of administration": "Irrigation"
  },
  {
    "Status": "Cancelled Post Market",
    "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14114",
    "DIN": "02008580",
    "Company": "3 WAY HERBS LTD. \n \n Castlegar \n \n British Columbia \n \n Canada \n V1N 3H4",
    "Product": "#17 DIURETIC TEA",
    "Class": "Human",
    "PM See footnote1": "No",
    "Schedule": "NON-PRESCRIPTION DRUGS",
    "# See footnote2": "9",
    "A.I. name See footnote3": "Active ingredient(s) \n See footnote 8",
    "Strength": "Strength",
    "Current status date": "2001-08-03",
    "Original market date": "1993-12-31",
    "Address": "Castlegar",
    "City": "British Columbia",
    "state": "Canada",
    "Country": "V1N 3H4",
    "Zipcode": "",
    "Number of active ingredient(s)": "9",
    "Biosimilar Biologic Drug": "No",
    "American Hospital Formulary Service (AHFS)": "92:01.00* \n See footnote 6",
    "Anatomical Therapeutic Chemical (ATC)": "",
    "Active ingredient group (AIG) number": "0924050001",
    "Labelling": "",
    "Product Monograph/Veterinary Date": "",
    "List of active ingredient": "Active ingredient(s) \n See footnote 8 : Strength\nCOUCH GRASS : 136 MG / 5 ML\nFENNEL : 136 MG / 5 ML\nGOOSE GRASS : 136 MG / 5 ML\nJUNIPER BERRIES : 136 MG / 5 ML\nPARSLEY : 136 MG / 5 ML\nSHEPHERDS PURSE : 136 MG / 5 ML\nTARAXACUM OFFICINALE WEBER : 136 MG / 5 ML\nUVA URSI : 136 MG / 5 ML\nZEA MAYS : 136 MG / 5 ML",
    "Dosage form": "Tea (Herbal)",
    "Route(s) of administration": "Oral"
  },
  {
    "Status": "Cancelled Post Market",
    "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14096",
    "DIN": "01996878",
    "Company": "3 WAY HERBS LTD. \n \n Castlegar \n \n British Columbia \n \n Canada \n V1N 3H4",
    "Product": "#7 NERVE TEA",
    "Class": "Human",
    "PM See footnote1": "No",
    "Schedule": "NON-PRESCRIPTION DRUGS",
    "# See footnote2": "9",
    "A.I. name See footnote3": "Active ingredient(s) \n See footnote 8",
    "Strength": "Strength",
    "Current status date": "2001-08-03",
    "Original market date": "1993-12-31",
    "Address": "Castlegar",
    "City": "British Columbia",
    "state": "Canada",
    "Country": "V1N 3H4",
    "Zipcode": "",
    "Number of active ingredient(s)": "9",
    "Biosimilar Biologic Drug": "No",
    "American Hospital Formulary Service (AHFS)": "92:01.00* \n See footnote 6",
    "Anatomical Therapeutic Chemical (ATC)": "",
    "Active ingredient group (AIG) number": "0948751001",
    "Labelling": "",
    "Product Monograph/Veterinary Date": "",
    "List of active ingredient": "Active ingredient(s) \n See footnote 8 : Strength\nCHAMOMILE : 16 %\nHOPS : 4 %\nMOTHERWORT COMMON : 10 %\nMUGWORT : 8 %\nPASSION FLOWER : 16 %\nROSMARINUS OFFICINALIS : 4 %\nSCULLCAP : 4 %\nVALERIAN : 8 %\nVERBENA OFFICINALIS : 8 %",
    "Dosage form": "Tea (Herbal)",
    "Route(s) of administration": "Oral"
  },
  {
    "Status": "Marketed",
    "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3132",
    "DIN": "00438014",
    "Company": "BAXTER CORPORATION \n \n 7125 Mississauga Road \n \n Mississauga \n \n Ontario \n \n Canada \n L5N 0C2",
    "Product": "(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP",
    "Class": "Human",
    "PM See footnote1": "Yes",
    "Schedule": "Ethical",
    "# See footnote2": "3",
    "A.I. name See footnote3": "Active ingredient(s) \n See footnote 8",
    "Strength": "Strength",
    "Current status date": "2013-01-21",
    "Original market date": "1978-12-31",
    "Address": "7125 Mississauga Road",
    "City": "Mississauga",
    "state": "Ontario",
    "Country": "Canada",
    "Zipcode": "L5N 0C2",
    "Number of active ingredient(s)": "3",
    "Biosimilar Biologic Drug": "No",
    "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
    "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
    "Active ingredient group (AIG) number": "0300097026",
    "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
    "Product Monograph/Veterinary Date": "2016-04-07",
    "List of active ingredient": "Active ingredient(s) \n See footnote 8 : Strength\nDEXTROSE : 3.3 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 300 MG / 100 ML",
    "Dosage form": "Solution",
    "Route(s) of administration": "Intravenous"
  },
  {
    "Status": "Marketed",
    "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10866",
    "DIN": "00786292",
    "Company": "BAXTER CORPORATION \n \n 7125 Mississauga Road \n \n Mississauga \n \n Ontario \n \n Canada \n L5N 0C2",
    "Product": "(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP",
    "Class": "Human",
    "PM See footnote1": "Yes",
    "Schedule": "Ethical",
    "# See footnote2": "3",
    "A.I. name See footnote3": "Active ingredient(s) \n See footnote 8",
    "Strength": "Strength",
    "Current status date": "2013-01-21",
    "Original market date": "1990-12-31",
    "Address": "7125 Mississauga Road",
    "City": "Mississauga",
    "state": "Ontario",
    "Country": "Canada",
    "Zipcode": "L5N 0C2",
    "Number of active ingredient(s)": "3",
    "Biosimilar Biologic Drug": "No",
    "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
    "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
    "Active ingredient group (AIG) number": "0300097006",
    "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
    "Product Monograph/Veterinary Date": "2016-04-07",
    "List of active ingredient": "Active ingredient(s) \n See footnote 8 : Strength\nDEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 900 MG / 100 ML",
    "Dosage form": "Solution",
    "Route(s) of administration": "Intravenous"
  }
]